ID CNTFR_HUMAN Reviewed; 372 AA. AC P26992; Q5U050; DT 01-AUG-1992, integrated into UniProtKB/Swiss-Prot. DT 01-FEB-1996, sequence version 2. DT 24-JAN-2024, entry version 204. DE RecName: Full=Ciliary neurotrophic factor receptor subunit alpha; DE Short=CNTF receptor subunit alpha; DE Short=CNTFR-alpha; DE Flags: Precursor; GN Name=CNTFR; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=1648265; DOI=10.1126/science.1648265; RA Davis S., Aldrich T.H., Valenzuela D.M., Wong V., Furth M.E., Squinto S.P., RA Yancopoulos G.D.; RT "The receptor for ciliary neurotrophic factor."; RL Science 253:59-63(1991). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=7774913; DOI=10.1016/0888-7543(95)80121-2; RA Valenzuela D.M., Rojas E., le Beau M.M., Espinosa R., Brannan C.I., RA McClain J., Masiakowski P., Ip N.Y., Copeland N.G., Jenkins N.A., RA Yancopoulos G.D.; RT "Genomic organization and chromosomal localization of the human and mouse RT genes encoding the alpha receptor component for ciliary neurotrophic RT factor."; RL Genomics 25:157-163(1995). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RA Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., RA Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., RA Phelan M., Farmer A.; RT "Cloning of human full-length CDSs in BD Creator(TM) system donor vector."; RL Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15164053; DOI=10.1038/nature02465; RA Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., RA Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., RA Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S., RA Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K., RA Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y., RA Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C., RA Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E., RA Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M., RA Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J., RA Frankish A., Frankland J.A., French L., Fricker D.G., Garner P., RA Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S., RA Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E., RA Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D., RA Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E., RA Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K., RA Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S., RA Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J., RA Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E., RA McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V., RA Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S., RA Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K., RA Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J., RA Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., RA West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L., RA Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M., RA Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J., RA Dunham I.; RT "DNA sequence and analysis of human chromosome 9."; RL Nature 429:369-374(2004). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Brain; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP FUNCTION, AND IDENTIFICATION IN HUMANIN RECEPTOR COMPLEX. RX PubMed=19386761; DOI=10.1091/mbc.e09-02-0168; RA Hashimoto Y., Kurita M., Aiso S., Nishimoto I., Matsuoka M.; RT "Humanin inhibits neuronal cell death by interacting with a cytokine RT receptor complex or complexes involving CNTF receptor alpha/WSX-1/gp130."; RL Mol. Biol. Cell 20:2864-2873(2009). RN [8] RP FUNCTION, AND INTERACTION WITH CLCF1; CRLF1 AND SORL1. RX PubMed=26858303; DOI=10.1128/mcb.00917-15; RA Larsen J.V., Kristensen A.M., Pallesen L.T., Bauer J., Vaegter C.B., RA Nielsen M.S., Madsen P., Petersen C.M.; RT "Cytokine-like factor 1, an essential facilitator of cardiotrophin-like RT cytokine:ciliary neurotrophic factor receptor alpha signaling and sorLA- RT mediated turnover."; RL Mol. Cell. Biol. 36:1272-1286(2016). RN [9] RP STRUCTURE BY NMR OF 202-305. RX PubMed=12707266; DOI=10.1074/jbc.m301976200; RA Man D., He W., Sze K.H., Gong K., Smith D.K., Zhu G., Ip N.Y.; RT "Solution structure of the C-terminal domain of the ciliary neurotrophic RT factor (CNTF) receptor and ligand free associations among components of the RT CNTF receptor complex."; RL J. Biol. Chem. 278:23285-23294(2003). CC -!- FUNCTION: Binds to CNTF. The alpha subunit provides the receptor CC specificity. Receptor for heterodimeric neurotropic cytokine composed CC of CLCF1/CLC and CRLF1/CLF-1 (PubMed:26858303). Acts as a receptor for CC the neuroprotective peptide humanin as part of a complex with CC IL6ST/GP130 and IL27RA/WSX1 (PubMed:19386761). CC {ECO:0000269|PubMed:19386761, ECO:0000269|PubMed:26858303}. CC -!- SUBUNIT: Forms a heterotrimer with LIFR and IL6ST. Interacts with CC heterodimeric neurotropic cytokine composed of CLCF1/CLC and CRLF1/CLF- CC 1 (PubMed:26858303). Either alone or in complex with the heterodimer CC CLCF1-CRLF1 interacts with SORL1; this interaction may promote CC internalization and lysosomal degradation (PubMed:26858303). Component CC of a receptor complex composed of IL6ST/GP130, IL27RA/WSX1 and CNTFR CC which interacts with the neuroprotective peptide humanin CC (PubMed:19386761). {ECO:0000269|PubMed:19386761, CC ECO:0000269|PubMed:26858303}. CC -!- INTERACTION: CC P26992; PRO_0000015616 [Q9UBD9]: CLCF1; NbExp=3; IntAct=EBI-743758, EBI-25298664; CC P26992; P26441: CNTF; NbExp=13; IntAct=EBI-743758, EBI-1050897; CC P26992; Q92673: SORL1; NbExp=7; IntAct=EBI-743758, EBI-1171329; CC -!- SUBCELLULAR LOCATION: Cell membrane; Lipid-anchor, GPI-anchor. CC -!- TISSUE SPECIFICITY: Nervous system and skeletal muscle. CC -!- DOMAIN: The WSXWS motif appears to be necessary for proper protein CC folding and thereby efficient intracellular transport and cell-surface CC receptor binding. CC -!- SIMILARITY: Belongs to the type I cytokine receptor family. Type 3 CC subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M73238; AAA35707.1; -; mRNA. DR EMBL; L38025; AAA91337.1; -; Genomic_DNA. DR EMBL; L38022; AAA91337.1; JOINED; Genomic_DNA. DR EMBL; L38023; AAA91337.1; JOINED; Genomic_DNA. DR EMBL; L38024; AAA91337.1; JOINED; Genomic_DNA. DR EMBL; BT019824; AAV38627.1; -; mRNA. DR EMBL; AL160270; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471071; EAW58445.1; -; Genomic_DNA. DR EMBL; CH471071; EAW58446.1; -; Genomic_DNA. DR EMBL; CH471071; EAW58447.1; -; Genomic_DNA. DR EMBL; CH471071; EAW58448.1; -; Genomic_DNA. DR EMBL; BC001492; AAH01492.1; -; mRNA. DR CCDS; CCDS6558.1; -. DR PIR; A40854; UHHUCN. DR RefSeq; NP_001193940.1; NM_001207011.1. DR RefSeq; NP_001833.1; NM_001842.4. DR RefSeq; NP_671693.1; NM_147164.2. DR RefSeq; XP_016869752.1; XM_017014263.1. DR RefSeq; XP_016869753.1; XM_017014264.1. DR RefSeq; XP_016869754.1; XM_017014265.1. DR PDB; 1UC6; NMR; -; A=202-305. DR PDB; 8D74; EM; 3.03 A; C=23-342. DR PDB; 8D7E; EM; 2.93 A; C=23-342. DR PDB; 8D7H; EM; 3.40 A; C/G=23-342. DR PDB; 8D7R; EM; 3.90 A; C=23-346. DR PDBsum; 1UC6; -. DR PDBsum; 8D74; -. DR PDBsum; 8D7E; -. DR PDBsum; 8D7H; -. DR PDBsum; 8D7R; -. DR AlphaFoldDB; P26992; -. DR BMRB; P26992; -. DR EMDB; EMD-27227; -. DR EMDB; EMD-27228; -. DR EMDB; EMD-27229; -. DR EMDB; EMD-27230; -. DR EMDB; EMD-27231; -. DR SMR; P26992; -. DR BioGRID; 107671; 18. DR CORUM; P26992; -. DR DIP; DIP-5777N; -. DR IntAct; P26992; 15. DR MINT; P26992; -. DR STRING; 9606.ENSP00000368265; -. DR TCDB; 8.A.152.2.1; the interleukin receptor (ilr) family. DR GlyCosmos; P26992; 4 sites, No reported glycans. DR GlyGen; P26992; 4 sites. DR PhosphoSitePlus; P26992; -. DR BioMuta; CNTFR; -. DR DMDM; 1352099; -. DR EPD; P26992; -. DR jPOST; P26992; -. DR MassIVE; P26992; -. DR PaxDb; 9606-ENSP00000368265; -. DR PeptideAtlas; P26992; -. DR ProteomicsDB; 54371; -. DR Antibodypedia; 25488; 365 antibodies from 39 providers. DR DNASU; 1271; -. DR Ensembl; ENST00000351266.8; ENSP00000242338.4; ENSG00000122756.15. DR Ensembl; ENST00000378980.8; ENSP00000368265.3; ENSG00000122756.15. DR Ensembl; ENST00000610543.4; ENSP00000480451.1; ENSG00000122756.15. DR GeneID; 1271; -. DR KEGG; hsa:1271; -. DR MANE-Select; ENST00000378980.8; ENSP00000368265.3; NM_147164.3; NP_671693.1. DR UCSC; uc003zup.2; human. DR AGR; HGNC:2170; -. DR CTD; 1271; -. DR DisGeNET; 1271; -. DR GeneCards; CNTFR; -. DR HGNC; HGNC:2170; CNTFR. DR HPA; ENSG00000122756; Tissue enhanced (brain, skeletal muscle). DR MIM; 118946; gene. DR neXtProt; NX_P26992; -. DR OpenTargets; ENSG00000122756; -. DR PharmGKB; PA26684; -. DR VEuPathDB; HostDB:ENSG00000122756; -. DR eggNOG; ENOG502QUDK; Eukaryota. DR GeneTree; ENSGT00940000158864; -. DR InParanoid; P26992; -. DR OMA; KICDTGE; -. DR OrthoDB; 5346848at2759; -. DR PhylomeDB; P26992; -. DR TreeFam; TF331210; -. DR PathwayCommons; P26992; -. DR Reactome; R-HSA-6788467; IL-6-type cytokine receptor ligand interactions. DR SignaLink; P26992; -. DR SIGNOR; P26992; -. DR BioGRID-ORCS; 1271; 8 hits in 1141 CRISPR screens. DR ChiTaRS; CNTFR; human. DR EvolutionaryTrace; P26992; -. DR GenomeRNAi; 1271; -. DR Pharos; P26992; Tbio. DR PRO; PR:P26992; -. DR Proteomes; UP000005640; Chromosome 9. DR RNAct; P26992; Protein. DR Bgee; ENSG00000122756; Expressed in ventricular zone and 99 other cell types or tissues. DR ExpressionAtlas; P26992; baseline and differential. DR GO; GO:0016324; C:apical plasma membrane; IDA:CACAO. DR GO; GO:0070110; C:ciliary neurotrophic factor receptor complex; IDA:BHF-UCL. DR GO; GO:0097059; C:CNTFR-CLCF1 complex; IDA:BHF-UCL. DR GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central. DR GO; GO:0019898; C:extrinsic component of membrane; TAS:ProtInc. DR GO; GO:0005886; C:plasma membrane; TAS:Reactome. DR GO; GO:0004897; F:ciliary neurotrophic factor receptor activity; TAS:ProtInc. DR GO; GO:0019955; F:cytokine binding; IPI:HGNC-UCL. DR GO; GO:0004896; F:cytokine receptor activity; IBA:GO_Central. DR GO; GO:0005102; F:signaling receptor binding; IPI:BHF-UCL. DR GO; GO:0003360; P:brainstem development; IEA:Ensembl. DR GO; GO:0070120; P:ciliary neurotrophic factor-mediated signaling pathway; IDA:BHF-UCL. DR GO; GO:0097049; P:motor neuron apoptotic process; IEA:Ensembl. DR GO; GO:2000672; P:negative regulation of motor neuron apoptotic process; IEA:Ensembl. DR GO; GO:0043524; P:negative regulation of neuron apoptotic process; IMP:UniProtKB. DR GO; GO:0007399; P:nervous system development; TAS:ProtInc. DR GO; GO:0008284; P:positive regulation of cell population proliferation; IEA:Ensembl. DR GO; GO:0007548; P:sex differentiation; IEA:Ensembl. DR GO; GO:0007165; P:signal transduction; NAS:ProtInc. DR GO; GO:0060538; P:skeletal muscle organ development; IEA:Ensembl. DR GO; GO:0001967; P:suckling behavior; IEA:Ensembl. DR CDD; cd00063; FN3; 1. DR Gene3D; 2.60.40.10; Immunoglobulins; 3. DR InterPro; IPR003961; FN3_dom. DR InterPro; IPR036116; FN3_sf. DR InterPro; IPR003530; Hematopoietin_rcpt_L_F3_CS. DR InterPro; IPR007110; Ig-like_dom. DR InterPro; IPR036179; Ig-like_dom_sf. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003599; Ig_sub. DR InterPro; IPR003598; Ig_sub2. DR PANTHER; PTHR23036:SF21; CILIARY NEUROTROPHIC FACTOR RECEPTOR SUBUNIT ALPHA; 1. DR PANTHER; PTHR23036; CYTOKINE RECEPTOR; 1. DR Pfam; PF00041; fn3; 1. DR SMART; SM00060; FN3; 1. DR SMART; SM00409; IG; 1. DR SMART; SM00408; IGc2; 1. DR SUPFAM; SSF49265; Fibronectin type III; 2. DR SUPFAM; SSF48726; Immunoglobulin; 1. DR PROSITE; PS50853; FN3; 2. DR PROSITE; PS01354; HEMATOPO_REC_L_F3; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR Genevisible; P26992; HS. PE 1: Evidence at protein level; KW 3D-structure; Cell membrane; Disulfide bond; Glycoprotein; GPI-anchor; KW Immunoglobulin domain; Lipoprotein; Membrane; Receptor; Reference proteome; KW Repeat; Signal. FT SIGNAL 1..22 FT /evidence="ECO:0000255" FT CHAIN 23..342 FT /note="Ciliary neurotrophic factor receptor subunit alpha" FT /id="PRO_0000010991" FT PROPEP 343..372 FT /note="Removed in mature form" FT /evidence="ECO:0000255" FT /id="PRO_0000010992" FT DOMAIN 27..104 FT /note="Ig-like C2-type" FT DOMAIN 108..205 FT /note="Fibronectin type-III 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 206..306 FT /note="Fibronectin type-III 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT REGION 301..340 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 290..294 FT /note="WSXWS motif" FT COMPBIAS 312..330 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT LIPID 342 FT /note="GPI-anchor amidated serine" FT /evidence="ECO:0000255" FT CARBOHYD 60 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 70 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 142 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 190 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 46..89 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114" FT STRAND 32..37 FT /evidence="ECO:0007829|PDB:8D7E" FT STRAND 42..44 FT /evidence="ECO:0007829|PDB:8D7E" FT STRAND 51..53 FT /evidence="ECO:0007829|PDB:8D7E" FT STRAND 55..59 FT /evidence="ECO:0007829|PDB:8D7E" FT HELIX 66..68 FT /evidence="ECO:0007829|PDB:8D7E" FT STRAND 73..76 FT /evidence="ECO:0007829|PDB:8D7E" FT HELIX 81..83 FT /evidence="ECO:0007829|PDB:8D7H" FT STRAND 85..91 FT /evidence="ECO:0007829|PDB:8D7E" FT STRAND 97..106 FT /evidence="ECO:0007829|PDB:8D7E" FT STRAND 113..119 FT /evidence="ECO:0007829|PDB:8D7E" FT STRAND 121..123 FT /evidence="ECO:0007829|PDB:8D7E" FT STRAND 126..130 FT /evidence="ECO:0007829|PDB:8D7E" FT STRAND 140..147 FT /evidence="ECO:0007829|PDB:8D7E" FT STRAND 159..162 FT /evidence="ECO:0007829|PDB:8D7E" FT STRAND 177..184 FT /evidence="ECO:0007829|PDB:8D7E" FT STRAND 189..196 FT /evidence="ECO:0007829|PDB:8D7E" FT TURN 198..200 FT /evidence="ECO:0007829|PDB:8D7H" FT STRAND 211..213 FT /evidence="ECO:0007829|PDB:8D7E" FT STRAND 223..225 FT /evidence="ECO:0007829|PDB:8D7E" FT STRAND 236..238 FT /evidence="ECO:0007829|PDB:8D7E" FT STRAND 243..251 FT /evidence="ECO:0007829|PDB:8D7E" FT STRAND 255..258 FT /evidence="ECO:0007829|PDB:8D74" FT STRAND 261..266 FT /evidence="ECO:0007829|PDB:8D7E" FT STRAND 272..274 FT /evidence="ECO:0007829|PDB:8D7E" FT STRAND 276..280 FT /evidence="ECO:0007829|PDB:8D7E" FT STRAND 283..288 FT /evidence="ECO:0007829|PDB:8D7E" FT STRAND 295..299 FT /evidence="ECO:0007829|PDB:1UC6" SQ SEQUENCE 372 AA; 40633 MW; B2F3F73DE8F8750E CRC64; MAAPVPWACC AVLAAAAAVV YAQRHSPQEA PHVQYERLGS DVTLPCGTAN WDAAVTWRVN GTDLAPDLLN GSQLVLHGLE LGHSGLYACF HRDSWHLRHQ VLLHVGLPPR EPVLSCRSNT YPKGFYCSWH LPTPTYIPNT FNVTVLHGSK IMVCEKDPAL KNRCHIRYMH LFSTIKYKVS ISVSNALGHN ATAITFDEFT IVKPDPPENV VARPVPSNPR RLEVTWQTPS TWPDPESFPL KFFLRYRPLI LDQWQHVELS DGTAHTITDA YAGKEYIIQV AAKDNEIGTW SDWSVAAHAT PWTEEPRHLT TEAQAAETTT STTSSLAPPP TTKICDPGEL GSGGGPSAPF LVSVPITLAL AAAAATASSL LI //